Heart disease is a global health problem with no geographic, gender, or socio-economic boundaries. Despite
the tremendous advances in cardiac care have been made recently, including drugs, devices, and diagnostic
innovation, many patients continue to die from heart disease or live with signifi cant morbidity. This conference
brings together the most exciting advances in cardiovascular disease and related cardiometabolic medicine,
from treatment to prevention, and innovation to application. The program is unique because of its translational
theme. The global faculty and participating audience present the faces of cardiovascular medicine with a truly
international perspective.
Challenges for the next decade include health promotion and disease prevention, where we must broaden our
scope of intervention to emphasize and extend preventive strategies, and translate our innovations into actions
through carefully designed health policy strategies. Genomic and proteomic biomarkers promise to improve
early detection and risk stratifi cation, leading to a more personalized approach to cardiovascular medicine.
Chronic disease management including hypertension, obesity and diabetes, and management of acute heart failure, cardiac arrhythmias, imaging techniques, and latest cardiovascular guidelines will be highlighted. The most up to date clinical trials will be featured in order to bring cardiovascular specialists the most novel approaches to disease management. A major focus this year will be on cardiovascular approaches for the primary care physician. Our symposium will off er the opportunity for all of our colleagues to come together in a user-friendly environment.